Targeting the Undruggable

Emerging Degrader Modalities

Features experts from Clarivate, Nurix, Triana, and Monte Rosa discussing how degrader modalities are transforming discovery pipelines.

Key takeaways:

Identifying and validating degrader targets
Understanding mechanisms impacting efficacy and safety
Evaluating early safety signals and preclinical data
Monitoring competitive landscape and emerging trends

Download Now

By submitting this form, you agree to the Terms & Conditions and acknowledge that your personal information will be processed in accordance with the Privacy Statement.

Sponsored by:

Targeting the Undruggable

Emerging Degrader Modalities

Key takeaways:

Download Now